Growth Metrics

Fulgent Genetics (FLGT) Current Assets (2016 - 2026)

Fulgent Genetics' Current Assets history spans 12 years, with the latest figure at $479.0 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 14.94% to $479.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $479.0 million, a 14.94% increase, with the full-year FY2025 number at $550.5 million, up 55.69% from a year prior.
  • Current Assets hit $479.0 million in Q1 2026 for Fulgent Genetics, down from $550.5 million in the prior quarter.
  • Over the last five years, Current Assets for FLGT hit a ceiling of $765.3 million in Q1 2022 and a floor of $326.5 million in Q3 2024.
  • Historically, Current Assets has averaged $516.5 million across 5 years, with a median of $507.8 million in 2023.
  • Biggest five-year swings in Current Assets: plummeted 40.61% in 2024 and later surged 55.69% in 2025.
  • Tracing FLGT's Current Assets over 5 years: stood at $627.9 million in 2022, then decreased by 19.12% to $507.8 million in 2023, then tumbled by 30.38% to $353.6 million in 2024, then soared by 55.69% to $550.5 million in 2025, then dropped by 12.98% to $479.0 million in 2026.
  • Business Quant data shows Current Assets for FLGT at $479.0 million in Q1 2026, $550.5 million in Q4 2025, and $507.4 million in Q3 2025.